PAH and pulmonary arterial hypertension: Fortunately, a murine model of human PAH deficiency, the Pahenu2/enu2 mouse49, which harbors a missense mutation in the Pah gene50 and recapitulates the major features of human PKU, has been available for use as a test bed for novel treatments.